Cargando…
The Dynamics of Nucleotide Variants in the Progression from Low–Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach
SIMPLE SUMMARY: Multiple myeloma (MM), characterized by the expansion of plasma cells in the bone marrow, is the second most common hematological malignancy. This incurable cancer is consistently preceded by non-malignant asymptomatic precursor conditions known as monoclonal gammopathy of undetermin...
Autores principales: | Oben, Bénedith, Cosemans, Charlotte, Geerdens, Ellen, Linsen, Loes, Vanhees, Kimberly, Maes, Brigitte, Theunissen, Koen, Cruys, Bert, Lionetti, Marta, Arijs, Ingrid, Bolli, Niccolò, Froyen, Guy, Rummens, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870380/ https://www.ncbi.nlm.nih.gov/pubmed/35205782 http://dx.doi.org/10.3390/cancers14041035 |
Ejemplares similares
-
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
por: Oben, Bénedith, et al.
Publicado: (2021) -
Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors
por: Froyen, Guy, et al.
Publicado: (2022) -
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
por: Lionetti, Marta, et al.
Publicado: (2021) -
The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020) -
Raising to the Challenge: Building a Federated Biobank to Accelerate Translational Research—The University Biobank Limburg
por: Linsen, Loes, et al.
Publicado: (2019)